CoChat

Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer

Published version of a preprint

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Ubiquitin-specific protease 10 (USP10) is known to deubiquitylate its target proteins, mainly to enhance their stabilities. USP10 maintains p53 protein levels and controls epigenetic changes induced by the androgen receptor (AR). GTPase-activating protein-binding protein 2 (G3BP2), an androgen-responsive gene, is known as the main component of stress granules (SG) that interacts with USP10 in SGs. This study explores the roles of USP10 in prostate cancer progression in p53, G3BP2, and AR signaling. Using chromatin immunoprecipitation (ChIP) and sequence analysis, it was found that USP10 is transcriptionally induced with AR recruitment to an intronic region. Furthermore, USP10 regulates androgen-mediated signaling and cell growth. USP10 maintained G3BP2 protein stability by reducing polyubiquitylation. G3BP2-dependent growth activation and p53 nuclear export that reduced p53 signaling were repressed by USP10 knockdown. Clinically, USP10 was expressed primarily in the cytoplasm of prostate cancer tissues. High levels of USP10 expression were strongly correlated with high levels of AR, G3BP2, and p53 in the cytoplasm. High expression of USP10 was significantly associated with poor prognosis of patients with prostate cancer. Taken together, USP10 has a repressive effect on p53 signaling for cell growth by regulating G3BP2 expression. These findings highlight an important oncogenic aspect of USP10 through its modulation of the p53–G3BP2 complex and AR signaling in prostate cancer. Implications: These findings elucidate the oncogenic role of USP10 in prostate cancer through an increase in G3BP2 protein that inhibits p53 activity, in addition to the promotion of AR signaling. Mol Cancer Res; 16(5); 846–56. ©2018 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/1541-7786.mcr-17-0471

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

1 retracted

Show all 43 references

Cited by

See all 105

Metadata

Authors
Takayama, K.-I., Suzuki, T., Fujimura, T., Takahashi, S., & Inoue, S.
Affiliations
  • Tokyo Metropolitan Institute of Gerontology (JP)
  • Tohoku University (JP)
  • The University of Tokyo (JP)
  • Nihon University (JP)
Venue
Molecular Cancer Research
Published
2018-04-30
Volume
16
Issue
5
Pages
846-856
ISSN
  • 1541-7786 (ISSN-L)
  • 1557-3125
OpenAlex
W2787104816
Cited by
104
References
43
Citations by year
2026: 7 · 2025: 9 · 2024: 7 · 2023: 21 · 2022: 14 · 2021: 18 · 2020: 13 · 2019: 6 · 2018: 9
FWCI
4.19
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
JSPS (15K15581, 15K15353, 17H04334)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
USP10, G3BP2, p53 pathway, prostate cancer, androgen receptor signaling, stress granules, polyubiquitination, protein stability, prognosis, androgen-regulated genes
MeSH terms
Carrier Proteins, Humans, Male, Prognosis, Prostatic Neoplasms, Receptors, Androgen, Signal Transduction, Tumor Suppressor Protein p53, RNA-Binding Proteins, Ubiquitin Thiolesterase, Adaptor Proteins, Signal Transducing, Cell Proliferation, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-17-0471
The paper
Takayama, K.-I., Suzuki, T., Fujimura, T., Takahashi, S., & Inoue, S. (2018). Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-17-0471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.